ABSTRACT-
cis-Diamminedichloroplatinum II (cisplatin), a nephrotoxic antineoplastic drug, increases lipid peroxidation in renal tissue, and this increase of lipid peroxides is prevented by an antioxidant, suggesting that free radicals or lipid peroxidation are responsible for the nephrotoxicity (1, 2) . Cellular glutathione (GSH) is important in the protection of cells from free radicals and peroxides (3, 4) . Diethylmaleate (DEM), a GSH depletor that conjugates with GSH (5), increases the nephrotoxicity of cisplatin (6) and the lipid peroxidation caused by this drug in renal cortical slices (7) . Cisplatin inhibits mitochondrial swelling induced by phosphate and mitochondrial respiration in vitro (8) and causes morphologic changes in mitochondria in vivo (9) . So, the mitochondria are a possible target site of the drug in renal cells. The aim of the study reported here was to examine changes in calcium uptake and GSH concentration in mitochondria isolated from rat kidney cortical slices incubated in the oresene of cisplatin with the GSH depletor DEM.
Kidney cortical slices were prepared from male Sprague-Dawley rats weighing 200 -250 g and anesthetized with sodium pentobarbital (50 mg/kg, i.p.) as described elsewhere (10) . The slices were incubated at 37°C for 60 min in a medium containing 134 mM NaCI, 5.9 mM KCI, 1.5 mM CaC12, 1.2 mM MgC12, 11.5 mM glucose, and 5.8 mM N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid titrated with NaOH at pH 7.4 in the presence or absence of cisplatin (Sigma Chemical Co., St. Louis, MO) with or without DEM (Wako Pure Chemical Industries, Ltd., Osaka). When incubation was over, GSH as a nonprotein sulfhydryl in the slices was assayed by the method of Ellman (11), and mitochondria were prepared from the slices for the measurement of GSH and cisplatin based on atomic absorption spectrometry of platinum. The isolated mitochondria were incubated at 37°C for 10 min in a medium containing 140 mM KCI, 10 mM Tris-HC1 buffer (pH 7.4), 50 mM sucrose, 2 mM MgCl2, 0.5 mM CaC12, and 2 mM ATP (Tris salt) for the assay of calcium up-* To whom all correspondence should be addressed .
take, which was determined by an atomi( absorption spectrophotometer, as previousl` reported (12) . Uptake was calculated by sub traction of the calcium content before incuba tion from that after incubation. DEM was dis solved in dimethyl sulfoxide. Values are ex pressed as means ± S.E. Statistical analysis was done by Student's t-test. The effects of cisplatin and DEM on the GSH level in rat kidney cortical slices an( mitochondria are shown in Table 1 . The de. crease in the GSH level in the control slice after 60 min of incubation was enhanced b} cisplatin or DEM alone. This decrease in the slices was further enhanced by the combination of the two. DEM had no effect or mitochondrial GSH but enhanced the cisplatin-induced decrease in mitochondria) GSH. The next experiments were designed tc study the effect of cisplatin on calcium uptake. a functional activity of mitochondria, in association with the movement of cisplatin into the mitochondria as evaluated by the platinum level. There was a tendency for the calcium uptake in mitochondria isolated from the slices treated with cisplatin to decrease, but it was not significant (Fig. 1) . The combination of cisplatin and DEM markedly inhibited calcium uptake by mitochondria, although DEM alone did not affect the uptake at all (data not shown). Cisplatin moved into mitochondria in the slices, and DEM had no effect on the movement.
In renal cortical cells, GSH is distributed between the cytoplasmic and mitochondrial pools, and the latter contains 72 percent of Fig. 1 . Calcium (Ca 2 ) uptake and the platinum (Pt) concentration in mitochondria isolated from rat kidney cortical slices incubated at 37°C for 60 min in a medium containing 1 mM cisplatin and 1 mM diethylmaleate. The isolated mitochondria were incubated at 37VC for 10 min for the measurement of calcium uptake. Diethylmaleate (2 mM) alone had no effect on calcium uptake by mitochondria; and for clarity, this uptake is not shown. Values are the means ± S.E. of at least six experiments. Table 1 . Effect of incubation with cisplatin together with diethylmaleate (DEM) on glutathione (GSH) levels in rat kidney cortical slices and in mitochondria isolated from the incubated slices Slices were incubated at 37'C for 60 min in a medium containing 1 mM cisplatin and 1 mM DEM. The concentration of DEM in "DEM alone" in the column of "mitochondrial GSH" was 2 mM . The mitochondrial GSH concentration of the control was 2.50 ± 0.25 nmol/mg protein. Values are the means ± S.E. of the number of experiments shown in parentheses. * P < 0.005 and **P < 0.001, compared to the control value; #P < 0.005 and ##P < 0.002, compared to "Cisplatin + DEM". GSH while the former contains the remaining 28 percent in renal proximal tubules (13) . DEM affected GSH in the slices without affecting the mitochondrial GSH level, suggesting that DEM depleted the cytoplasmic GSH. The kidney accumulates high concentrations of cisplatin injected into rats (14) , and the drug shows subcellular localization in kidney (15) . In our study, cisplatin moved into the mitochondria in rat kidney cortical slices in vitro, and such movement was not affected by the decrease in cytoplasmic GSH caused by DEM. When the slices were incubated with cisplatin alone for 60 min, calcium uptake by mitochondria tended to decrease in this study. Some preliminary experiments in our laboratory have shown that when the slices are incubated with cisplatin for 90 min, calcium uptake is significantly inhibited, indicating cisplatin itself has an effect on mitochondrial calcium uptake. So, the results suggest that cisplatin that moved into the mitochondria would depress both mitochondrial GSH content and the activity of calcium uptake by mitochondria. The suppressive effect of cisplatin on mitochondrial calcium uptake and GSH content was enhanced by DEM which decreased cytoplasmic GSH but did not influence mitochondrial cisplatin level. These results show that cytoplasmic GSH depletion promotes cisplatin-induced injury to mitochondria, suggesting an important role of cytoplasmic GSH in the effect of cisplatin on mitochondria in renal cells. It is not clear whether the inhibition of mitochondrial calcium uptake by cisplatin is due to its effect on the GSH level in mitochondria.
